Product Information
GONAL-F RFF REDI-JECT 450 UNIT PEN is a brand product labeled by EMD Serono, Inc., priced at $1846.9120 per ML under NDC 44087111601. Its NADAC has been published 68 times since Apr 17, 2024.
Strength
450 [iU]/.75mL
Manufacturer
EMD Serono, Inc.NDC
44087111601
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
10/23/2024
Active Ingredients
FOLLITROPINApproval Type
Biologic (BLA)
FDA Application
BLA021684On Market Since
10/16/2013
Pharmacological Classes
Price Statistics
The NADAC for GONAL-F RFF REDI-JECT 450 UNIT PEN has been published 68 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1846.9120 per ML |
|---|---|
| All-time high | $1850.3511 (Sep 11, 2024) |
| All-time low | $1846.9120 (Sep 18, 2024) |
| Median price | $1846.9120 |
| Average price | $1848.0247 |
| Largest weekly change | -0.2% (Sep 18, 2024) |
| Weeks tracked | 68 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-0.2%
Last surveyed Jul 30, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the FOLLITROPIN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
EMD Serono, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
FOLLITROPIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GONAL-F RFF REDI-JECT 450 UNIT PEN?
The current National Average Drug Acquisition Cost (NADAC) for GONAL-F RFF REDI-JECT 450 UNIT PEN, manufactured by EMD Serono, Inc., is $1846.9120 per ML (NDC 44087111601), effective Jul 30, 2025.
How has the price of GONAL-F RFF REDI-JECT 450 UNIT PEN changed over time?
Over the history we have for it, the NADAC for GONAL-F RFF REDI-JECT 450 UNIT PEN has held within roughly two percent of its current level. It has been tracked across 68 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for GONAL-F RFF REDI-JECT 450 UNIT PEN?
Since Apr 17, 2024, the NADAC for GONAL-F RFF REDI-JECT 450 UNIT PEN has ranged from a low of $1846.9120 (Sep 18, 2024) to a high of $1850.3511 (Sep 11, 2024), with a median of $1846.9120 per ML.
Are there cheaper alternatives to GONAL-F RFF REDI-JECT 450 UNIT PEN?
No other NADAC-published product currently shares the active ingredient and strength of GONAL-F RFF REDI-JECT 450 UNIT PEN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GONAL-F RFF REDI-JECT 450 UNIT PEN?
GONAL-F RFF REDI-JECT 450 UNIT PEN (NDC 44087111601) is labeled by EMD Serono, Inc., and CMS classifies it as a brand product.